GLYCOMIMETICS INC (GLYC)
US38000Q1022 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.16M -88.58% | 80K -93.10% | 10K -87.50% | -100.00% | 3.635M | 1.292M -64.46% | 6.518M 404.49% | 32.572M 399.72% | 77.156M 136.88% | 181.84M 135.68% | 121.38M -33.25% | |
| EBITDA YoY % growth | -63.19M -23.32% | -47.19M 25.32% | -39.122M 17.10% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -63.45M -23.18% | -47.4M 25.30% | -39.275M 17.14% | -33.887M 13.72% | -8.499M 74.92% | -6.366M 25.10% | -72.287M -1,035.56% | -58.154M 19.55% | -21.457M 63.10% | 73.137M 440.85% | 35.19M -51.88% | |
| Operating Margin | -5,469.83% | -59,250.00% | -392,752.90% | N/A | -233.80% | -492.71% | -1,109.04% | -178.54% | -27.81% | 40.22% | 28.99% | |
| EPS YoY % growth | -1.23 -10.81% | -0.88 28.46% | -0.58 34.09% | -0.62 -6.84% | -0.44 28.40% | -0.52 -17.24% | -0.69 -33.33% | -0.14 79.41% | 0.56 492.86% | 3.77 572.73% | N/A |
All data in USD
| Q3 / 24 | Q4 / 24 | |
|---|---|---|
| EPS Q2Q % growth | -0.11 19.86% | -0.16 -16.57% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -7.491M 23.64% | -11.837M -23.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.16 -23.08% | -0.17 | 0.01 | 6.35% |
| Q1 2024 Q2Q % growth | -0.17 | -0.17 | 0.00 | -1.01% |
| Q4 2023 Q2Q % growth | -0.14 26.32% | -0.16 | 0.02 | 10.00% |
| Q3 2023 Q2Q % growth | -0.14 12.50% | -0.15 | 0.01 | 4.24% |
| Q2 2023 Q2Q % growth | -0.13 48.00% | -0.19 | 0.06 | 30.48% |
| Q1 2023 Q2Q % growth | -0.17 39.29% | -0.17 | 0.00 | 0.00% |
| Q4 2022 Q2Q % growth | -0.19 42.42% | -0.17 | -0.02 | -11.76% |
| Q3 2022 Q2Q % growth | -0.16 52.94% | -0.27 | 0.11 | 40.43% |
| Q2 2022 Q2Q % growth | -0.25 10.71% | -0.29 | 0.04 | 14.00% |
| Q1 2022 Q2Q % growth | -0.28 | -0.31 | 0.03 | 10.49% |
| Q4 2021 Q2Q % growth | -0.33 -3.13% | -0.34 | 0.01 | 4.14% |
| Q3 2021 Q2Q % growth | -0.34 -17.24% | -0.32 | -0.02 | -4.99% |
| Q2 2021 Q2Q % growth | -0.28 12.50% | -0.31 | 0.03 | 10.73% |
| Q1 2021 Q2Q % growth | -0.28 -55.56% | -0.32 | 0.04 | 13.68% |
| Q4 2020 Q2Q % growth | -0.32 5.88% | -0.33 | 0.01 | 2.57% |
| Q3 2020 Q2Q % growth | -0.29 6.45% | -0.33 | 0.04 | 13.32% |
| Q2 2020 Q2Q % growth | -0.32 13.51% | -0.39 | 0.07 | 17.44% |
| Q1 2020 Q2Q % growth | -0.18 45.45% | -0.31 | 0.13 | 41.95% |
| Q4 2019 Q2Q % growth | -0.34 | -0.35 | 0.01 | 3.85% |
| Q3 2019 Q2Q % growth | -0.31 | -0.40 | 0.09 | 22.47% |
| Q2 2019 Q2Q % growth | -0.37 | -0.37 | 0.00 | 0.16% |
| Q1 2019 Q2Q % growth | -0.33 | -0.35 | 0.02 | 6.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | 20K -87.50% | 20K | % | |
| Q3 2021 Q2Q % growth | 90K -91.00% | 90K | % | |
| Q1 2021 Q2Q % growth | 1.06M -88.22% | 1.06M | % | |
| Q4 2020 Q2Q % growth | 160K | 204K | -44K | -21.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |